Dr. Ruxandra Gref is a Research Director at Paris Sud University, where they conduct multidisciplinary research in nanotechnology to tackle drug resistance. They engineer hydrogels and core-shell drug-loaded nanoparticles using a variety of materials. Additionally, Dr. Gref coordinates the Marie Curie European network "Cyclon Hit," which consists of 18 partners and 7 companies, focused on developing innovative drug delivery systems to combat resistant bacteria. Previously, Dr. Gref held a post-doctoral research position at MIT, specializing in surface-modified "stealth" nanoparticles for targeted drug delivery. Their academic background includes a Ph.D. in Chemical Engineering and Polymer Chemistry from the National School of Chemical Engineering.
This person is not in the org chart
This person is not in any teams
This person is not in any offices